Pricing Log in Create free account

BridgeBio Oncology Therapeutics, Inc (BBOT) vs MediWound Ltd. (MDWD)

BridgeBio Oncology Therapeutics, Inc and MediWound Ltd. are both Biotechnology companies. MediWound Ltd. is the larger, with a market value of $184.0M against $163.6M — 1.1× the size. BridgeBio Oncology Therapeutics, Inc has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (−127.7% vs −6,551.8%). Across the 12 metrics below, BridgeBio Oncology Therapeutics, Inc leads on 7 and MediWound Ltd. on 5.

Valuation

Metric BBOT MDWD Biotechnology median
P/E n/m n/m 10.60
P/S n/m 15.48 9.40
P/B 0.51 5.15 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.31 n/m 0.66
EV/Sales n/m 12.58 9.02
Earnings yield (135.29%) (11.23%) (32.88%)
Free cash flow yield (92.81%) (15.56%) (23.13%)

Profitability

Metric BBOT MDWD Biotechnology median
Gross margin — 15.46% 68.51%
Operating margin 0.00% (267.75%) 0.00%
Net margin 0.00% (170.10%) 0.00%
Free cash flow margin 0.00% (240.47%) 0.00%
Return on equity (252.10%) (75.42%) (51.96%)
Return on assets (96.69%) (29.06%) (46.06%)
Return on invested capital (127.66%) (6,551.77%) 0.00%

Growth

Metric BBOT MDWD Biotechnology median
Revenue growth (TTM) — (40.26%) 6.76%
EPS growth (last fiscal year) 99.93% 30.69% 29.88%
Revenue growth, 5-year CAGR — (4.87%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BBOT MDWD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.69 2.32 4.97
Net debt to EBITDA 2.93 2.27 1.01

Dividend

Metric BBOT MDWD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBOT MDWD Biotechnology median
Market cap 163.56m 183.97m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack